Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor
| author | |
| created | [InstanceEdit:9713889] Rothfels, Karen, 2021-02-02 |
| dbId | 9713886 |
| displayName | Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor |
| journal | Clin Lung Cancer |
| pages | 215-221 |
| pubMedIdentifier | 30683630 |
| schemaClass | LiteratureReference |
| title | Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor |
| url | http://www.ncbi.nlm.nih.gov/pubmed/30683630 |
| volume | 20 |
| year | 2019 |
Referrals
| (literatureReference) | |
| (author) |
© 2026 Reactome
